STRENSIQ 18 mg/.45mL

STRENSIQ 18 mg/0.45mL is a subcutaneous solution containing asfotase alfa, used for enzyme replacement therapy. This medication is designed to address specific metabolic conditions by replacing deficient enzymes.

STRENSIQ is primarily used in enzyme replacement therapy to manage conditions caused by enzyme deficiencies. It is often prescribed for patients who lack certain enzymes necessary for normal metabolic function. The medication works by providing the missing enzyme, helping to alleviate symptoms associated with these deficiencies.

Common effects of STRENSIQ may include reactions at the injection site, such as redness, swelling, or itching. Some users might experience fatigue or mild gastrointestinal discomfort. These effects are generally mild and temporary, but any persistent or severe reactions should be discussed with a healthcare provider.

STRENSIQ should be handled with care, following the instructions provided by the healthcare provider. It is important to store the medication properly and to use sterile techniques when administering the subcutaneous injections. Patients should be monitored for any signs of allergic reactions or other adverse effects.

STRENSIQ may interact with other medications or substances, so it is important to inform your healthcare provider about all the medications you are taking. Alcohol and certain other substances may affect the efficacy or safety of STRENSIQ, so it is advisable to avoid them unless directed otherwise by a healthcare professional.